Abstract:Alzheimer’s disease (AD) is known to be caused by multiple factors, meanwhile the pathogenic mechanism and development of AD associate closely with genetic factors. Existing understanding of the molecular mechanisms underlying AD remains incomplete. Gene expression data (GSE48350) derived from post-modern brain was extracted from the Gene Expression Omnibus (GEO) database. The differentially expressed genes (DEGs) were derived from hippocampus and entorhinal cortex regions between AD patients and healthy controls and detected via Morpheus. Functional enrichment analyses, including Gene Ontology (GO) and pathway analyses of DEGs, were performed via Cytoscape and followed by the construction of protein-protein interaction (PPI) network. Hub proteins were screened using the criteria: nodes degree≥10 (for hippocampus tissues) and ≥ 8 (for entorhinal cortex tissues). Molecular Complex Detection (MCODE) was used to filtrate the important clusters. University of California Santa Cruz (UCSC) and the database of RNA-binding protein specificities (RBPDB) were employed to identify the RNA-binding proteins of the long non-coding RNA (lncRNA). 251 & 74 genes were identified as DEGs, which consisted of 56 & 16 up-regulated genes and 195 & 58 down-regulated genes in hippocampus and entorhinal cortex, respectively. Biological analyses demonstrated that the biological processes and pathways related to memory, transmembrane transport, synaptic transmission, neuron survival, drug metabolism, ion homeostasis and signal transduction were enriched in these genes. 11 genes were identified as hub genes in hippocampus and entorhinal cortex, and 3 hub genes were identified as the novel candidates involved in the pathology of AD. Furthermore, 3 lncRNAs were filtrated, whose binding proteins were closely associated with AD. Through GO enrichment analyses, pathway analyses and PPI analyses, we showed a comprehensive interpretation of the pathogenesis of AD at a systematic biology level, and 3 novel candidate genes and 3 lncRNAs were identified as novel and potential candidates participating in the pathology of AD. The results of this study could supply integrated insights for understanding the pathogenic mechanism underlying AD and potential novel therapeutic targets.

Comprehensive computational analysis approach for Alzheimer's disease

[In Vitro Pathological Model of Alzheimer's Disease Based on Neuronal Network Chip and Its Real-Time Dynamic Analysis].

Identifying Shared Diagnostic Genes and Mechanisms in Vascular Dementia and Alzheimer's Disease Via Bioinformatics and Machine Learning

Integrated Identification of Key Genes and Pathways in Alzheimer’s Disease Via Comprehensive Bioinformatical Analyses

Analysis of Complement System and Its Related Factors in Alzheimer’s Disease

An Image Based System Biology Approach for Alzheimer's Disease Pathway Analysis

Network Medicine Approach for Analysis of Alzheimer's Disease Gene Expression Data.

An Integrated Genetics Approach for Identifying Protein Signal Pathways of Alzheimer's Disease

Comprehensive overview of Alzheimer's disease utilizing Machine Learning approaches

A review and analysis of key biomarkers in Alzheimer's disease

The Research Progress of the Application of Bioinformatics in the Diagnosis and Treatment of Alzheimer's Disease

Comprehensive Analysis Reveals A Six-Gene Signature and Associated Drugs in Alzheimer Disease

Revealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis

Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease

Revealing the Molecular Mechanisms of Alzheimer's Disease Based on Network Analysis.

Gene Network Analysis of Alzheimer’s Disease Based on Network and Statistical Methods

Key Network Approach Reveals New Insight into Alzheimer's Disease.

The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer's Disease.

Neuroimaging techniques, gene therapy, and gut microbiota: frontier advances and integrated applications in Alzheimer's Disease research

A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease

Computational Integration of Nanoscale Physical Biomarkers and Cognitive Assessments for Alzheimer’s Disease Diagnosis and Prognosis